Investing.com - Allergan (NYSE:AGN) reported third quarter earnings that beat analysts' expectations on Tuesday and revenue that topped forecasts.
The firm reported earnings per share of $4.25 on revenue of $4.05B. Analysts polled by Investing.com anticipated EPS of $4.23 on revenue of $3.89B. That compared to EPS of $4.25 on revenue of $3.91B in the same period a year earlier. The company had reported EPS of $4.38 on revenue of $4.09B in the previous quarter.
For the year, Allergan shares are up 33.77%, outperforming the S&P 500 which is up 24.28% year to date.
Allergan follows other major Healthcare sector earnings this month
On October 15, J&J reported third quarter EPS of $2.12 on revenue of $20.73B, compared to forecasts of EPS of $2.01 on revenue of $20.08B.
Merck&Co earnings beat analyst's expectations on October 29, with third quarter EPS of $1.51 on revenue of $12.4B. Investing.com analysts expected EPS of $1.24 on revenue of $11.64B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar